The Current State of Renal Replacement Therapy in the Treatment of Sepsis
| Autor: | T. G. Kim, M. А. Magomedov, D. N. Protsenko, M. V. Zakharov, А. V. Marukhov, N. V. Chubchenko |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Вестник анестезиологии и реаниматологии, Vol 18, Iss 4, Pp 80-89 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2078-5658 2541-8653 |
| DOI: | 10.21292/2078-5658-2021-18-4-80-89 |
| Popis: | Of all cases of acute kidney injury (AKI), 45-70% are associated with sepsis. Lethality in sepsis-associated AKI requiring renal replacement therapy (RRT) ranges from 40 to 50%, and in AKI combined with other organ dysfunctions - 60-80%. In order to improve the results of treatment of sepsis and septic shock, various methods of extracorporeal detoxification (ECD) have been developed. The effectiveness of these methods is controversial. In the treatment of sepsis, RRT is used not only to replace the impaired detoxification function of kidneys, but also to remove excess cytokines from the systemic bloodstream. The literature describes mainly positive results of the use of dialyzers with an adsorbing membrane, however, these data do not have the necessary degree of evidence. Currently, there are no clear criteria for the initiation of RRT, its duration and doses, the choice of methodology determined by specific clinical and laboratory parameters, and staging of this therapy. All this highlights the need for further research in this field. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|